BioNTech / Mainz, Germany
Ozlem Tureci
Ozlem Tureci carried lessons from an immigrant medical family into BioNTech: maintain scientific standards before recognition arrives, and build platforms that can move when the evidence changes.
Founder Record
Physician-scientist Ozlem Tureci co-founded BioNTech with Ugur Sahin and helped build its work in individualized cancer immunotherapy and messenger RNA into a platform capable of responding to COVID-19.
Timeline
- 2001Co-founded Ganymed Pharmaceuticals with Ugur Sahin and colleagues.
- 2008Co-founded BioNTech in Mainz to develop individualized immunotherapies.
- 2016Ganymed was acquired after years of cancer-antibody development.
- 2020BioNTech launched Project Lightspeed and developed an mRNA COVID-19 vaccine with Pfizer.
Defining Record
- Co-founded Ganymed Pharmaceuticals and BioNTech
- Built around cancer immunotherapy and messenger RNA
- Helped lead the rapid development of the Pfizer-BioNTech COVID-19 vaccine
Related Ledger Entries
Related Short Series
Related Context
Continue through the archive
One record should open another.
Follow the shared decisions, markets, constraints, and places surrounding this story.
01 / Ledger case fileOzlem Tureci: When Science Becomes SanctuaryOzlem Tureci helped build BioNTech in relative scientific obscurity before its messenger-RNA platform became central to the first widely deployed COVID-19 vaccines.20 minute read02 / Founder recordAndrea ReynoldsReynolds converted years of SME fundraising knowledge into a platform that helps business owners navigate loans, equity, grants, asset finance, and other funding routes.Swoop Funding / Dublin, Ireland03 / Field noteThe Immigrant Founder's Outsider AdvantageCrossing systems and cultures can make normalized friction visible and produce unusually global founder networks.Founder Perspective04 / Company recordBioNTechImmune-system platforms for individualized medicineBiotechnology and immunotherapy / Founded 2008